Loss of heterozygosity on chromosome 18q is associated with muscle-invasive transitional cell carcinoma of the bladder.

Somatic allelic loss is regarded as a hallmark of tumour-suppressor gene (TSG) inactivation. Thirty-one human bladder transitional cell carcinomas (TCCs) were examined for allelic loss at five chromosome 18q loci, including the DCC gene (deleted in colorectal carcinoma) and at chromosome 11p15 in a restriction fragment length polymorphism analysis. Allelic loss was observed at one or more 18q loci in 9/26 (35%) samples, associated with muscle-invasive disease (P < 0.02). Allelic loss was observed at DCC in 8/24 (33%) samples, associated with muscle-invasive disease (P = 0.05). Three out of the five evaluable recurrent TCCs exhibited allelic loss at DCC, two of which were superficial. No allelic losses were detected at other 18q loci in tumours which retained both DCC alleles. Allelic loss was observed at 11p15 in 5/20 (25%) tumours. These data suggest the presence of a late-acting TSG located on 18q in TCC bladder cancer. DCC is a candidate gene since it lies within the region of most common deletion (18q21.3-qter).

• Publication year

  1994

• Venue

  British Journal of Cancer

• Publication date

  1994-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/bjc.1994.376PMID 7917921PMCID 2033387
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Somatic allelic loss at the DCC, APC, nm23-H1 and p53 tumor suppressor gene loci in human prostatic carcinoma.

  1994cited by this paper
• Gene therapy in urological oncology: principles, strategies and potential.

  1994cited by this paper
• Genetic alterations in bladder cancer.

  1993cited by this paper
• Initiation of bladder cancer may involve deletion of a tumour-suppressor gene on chromosome 9.

  1993cited by this paper
• Accumulated allelic losses in the development of invasive urothelial cancer

  1993cited by this paper
• A molecular genetic model of human bladder carcinogenesis.

  1993cited by this paper
• Allele loss from 5q21 (APC/MCC) and 18q21 (DCC) and DCC mRNA expression in breast cancer.

  1993cited by this paper
• An association between the risk of cancer and mutations in the HRAS1 minisatellite locus.

  1993cited by this paper
• Frequent loss of heterozygosity at the DCC locus in gastric cancer.

  1992cited by this paper
• Clonal origin of bladder cancer.

  1992cited by this paper
• SAM 1.1 and JOSH 4.4: two RFLPs within the human DCC gene.

  1992cited by this paper
• Tumour suppressor genes in urinary tract oncology.

  1992cited by this paper
• Frequent loss of heterozygosity on chromosome 18 in ovarian adenocarcinoma which does not always include the DCC locus.

  1992cited by this paper
• Report of the committee on chromosome and gene loss in human neoplasia

  1991cited by this paper
• Loss of heterozygosity at the RB locus is frequent and correlates with muscle invasion in bladder carcinoma.

  1991cited by this paper
• Molecular genetic alterations in superficial and locally advanced human bladder cancer.

  1991cited by this paper
• Identification of a chromosome 18q gene that is altered in colorectal cancers.

  1990cited by this paper
• A genetic model for colorectal tumorigenesis.

  1990cited by this paper
• Allelic losses of chromosomes 9, 11, and 17 in human bladder cancer.

  1990cited by this paper
• Report of the committee on chromosome changes in neoplasia.

  1990cited by this paper
• A highly polymorphic locus on chromosome 11 which has homology to a collagen triple-helix coding sequence.

  1989cited by this paper
• Genetic alterations during colorectal-tumor development.

  1988cited by this paper
• RFLP identified by the anonymous DNA segment OL VII A8 at 18q11 (HGM8 no. D18S7).

  1987cited by this paper
• Assignment of a polymorphic locus of OS-4(D18S5) DNA segment to human chromosome region 18q21.3→qter

  1987cited by this paper
• The X chromosome shows less genetic variation at restriction sites than the autosomes.

  1986influential reference
• Characterization of a spontaneous mutation to a beta-thalassemia allele.

  1986cited by this paper
• Hypervariable ‘minisatellite’ regions in human DNA

  1985cited by this paper
• Loss of genes on the short arm of chromosome 11 in bladder cancer

  1985cited by this paper
• Expression of recessive alleles by chromosomal mechanisms in retinoblastoma

  1983cited by this paper
• Bladder carcinoma as a systemic disease

  1979cited by this paper
• A New Theory on the Cancer-inducing Mechanism

  1953cited by this paper

• Are We Benign? What Can Wnt Signaling Pathway and Epithelial to Mesenchymal Transition Tell Us about Intracranial Meningioma Progression

  2021cites this paper
• Aspects of Development and Progression of Bladder Cancer 2

  2019cites this paper
• Impact of SNPs on CpG Islands in the MYC and HRAS oncogenes and in a wide variety of tumor suppressor genes: A multi-cancer approach

  2016cites this paper
• Loss of heterozygosis on chromosome 18q21-23 and muscle-invasive bladder cancer natural history.

  2015cites this paper
• Bladder Cancer: General Features

  2012cites this paper
• Influence of deleted in colorectal carcinoma gene on proliferation of ovarian cancer cell line SKOV-3 in vivo and in vitro.

  2011cites this paper
• Prognostic role of loss of heterozygosity on chromosome 18 in patients with low-risk nonmuscle-invasive bladder cancer: results from a prospective study.

  2010cites this paper
• Neoexpression von Netrin-1, UNC5H3, DCC und Neogenin in duktalen Adenokarzinomen des Pankreas. Mögliche prognostische Marker mit therapeutischer Relevanz?

  2008cites this paper
• Molecular biology of bladder cancer

  2007cites this paper
• Tumor suppressor loci in bladder cancer.

  2007cites this paper
• Prognostic Implications of Netrin-1 Expression and Its Receptors in Patients with Adenocarcinoma of the Pancreas

  2007cites this paper
• Human Lung Cancers Gene at 18 q 21 in DPC 4 Alterations of the in Vivo Somatic Updated

  2006cites this paper
• Tumor Progression Evidence That Loss of Chromosome 18 q Is Associated with Updated

  2006cites this paper
• Genomic instability analysis of urine sediment versus tumor tissue in transitional cell carcinoma of the urinary bladder.

  2006cites this paper
• Detection of chromosomal alterations in bladder transitional cell carcinomas from Northern China by comparative genomic hybridization.

  2006cites this paper
• Allelotype of Pancreatic Adenocarcinoma Using Xenograft Enrichment 1

  2006cites this paper
• High-density single nucleotide polymorphism array defines novel stage and location-dependent allelic imbalances in human bladder tumors.

  2005cites this paper
• Netrin-1: when a neuronal guidance cue turns out to be a regulator of tumorigenesis

  2005cites this paper
• Oligoclonality in bladder cancer: the implication for molecular therapies.

  2004cites this paper
• Expression of DCC and netrin-1 in normal human endometrium and its implication in endometrial carcinogenesis.

  2004cites this paper
• The role of cell adhesion molecule in cancer progression and its application in cancer therapy.

  2004cites this paper
• Role of the dependence receptor DCC in colorectal cancer pathogenesis.

  2004cites this paper
• Deleted-in-colon-cancer protein expression in patients with adenocarcinoma of the urinary tract and a history of colorectal cancer.

  2004cites this paper
• Loss of chromosome arm 18q with tumor progression in head and neck squamous cancer

  2004cites this paper
• Netrin-1 and its receptors in tumorigenesis

  2004cites this paper
• The relationship of BRMS1 and RhoGDI2 gene expression to metastatic potential in lineage related human bladder cancer cell lines

  2004cites this paper
• The dependence receptors DCC and UNC5H as a link between neuronal guidance and survival

  2003cites this paper
• A partial allelotyping of urothelial carcinoma of bladder in the Chinese.

  2003influential citation
• Fragile sites and bladder cancer.

  2003cites this paper
• Molecular pathogenesis of urothelial bladder cancer.

  2003cites this paper
• Clinical significance of allelotype profiling for urothelial carcinoma.

  2003cites this paper
• Vysis® UroVysion for the detection of urothelial carcinoma

  2003cites this paper
• Novel chromosome findings in bladder cancer cell lines detected with multiplex fluorescence in situ hybridization.

  2002cites this paper
• Cell adhesion proteins as tumor suppressors.

  2002cites this paper
• Functional genomic comparison of lineage-related human bladder cancer cell lines with differing tumorigenic and metastatic potentials by spectral karyotyping, comparative genomic hybridization, and a novel method of positional expression profiling.

  2002influential citation
• The Molecular Basis of Prostate Carcinogenesis

  2002cites this paper
• Prospective evaluation of genetic abnormalities and telomerase expression in exfoliated urinary cells for bladder cancer detection.

  2002cites this paper
• What we could do now: molecular pathology of bladder cancer

  2001cites this paper
• Definition of a 1-Mb homozygous deletion at 9q32-q33 in a human bladder-cancer cell line

  2001cites this paper
• [Fundamental bases of urothelial carcinogenesis].

  2001cites this paper
• Functional analysis of the mismatch repair system in bladder cancer

  2001cites this paper
• Somatic alterations of the DPC4 and Madr2 genes in colorectal cancers and relationship to metastasis.

  2001cites this paper
• Bases fondamentales de la carcinogenèse urothéliale.

  2001cites this paper
• The Molecular Pathogenesis of Bladder Cancer

  2001cites this paper
• Biology and Molecular Aspects of Development and Progression of Bladder Cancer

  2001cites this paper
• Suppressed tumorigenicity of human endometrial cancer cells by the restored expression of the DCC gene

  2000cites this paper
• High frequency loss of heterozygosity in the region of the DBH locus in bladder cancer.

  2000cites this paper
• Biología molecular en el cáncer vesical

  2000cites this paper
• Epidemiology and biology of human urinary bladder cancer

  2000cites this paper
• Reduced or absent expression and codon 201Gly/Arg polymorphism of DCC gene in rhabdomyosarcoma and Ewing's sarcoma/PNET family.

  2000cites this paper
• [Molecular biology in bladder cancer].

  2000cites this paper
• Genetic and phenotypic changes associated with the acquisition of tumorigenicity in human bladder cancer

  2000cites this paper
• Microsatellite analysis in multiple chromosomal regions as a prognostic indicator of primary bladder cancer

  2000cites this paper
• The genetics of transitional cell carcinoma: progress and potential clinical application

  1999cites this paper
• Evidence for two candidate tumour suppressor loci on chromosome 9q in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder tumour cell lines

  1999cites this paper
• Role of adhesion molecules in bladder cancer: an important part of the jigsaw.

  1999cites this paper
• Partial allelotype of schistosomiasis‐associated bladder cancer

  1999cites this paper
• Somatic mutation of PTEN in bladder carcinoma

  1999cites this paper
• Limiting the location of putative human prostate cancer tumor suppressor genes on chromosome 18q

  1999cites this paper
• Localization of tumor suppressor gene associated with distant metastasis of urinary bladder cancer to a 1‐Mb interval on 8p22

  1999cites this paper
• Identification of novel bladder tumour suppressor genes

  1999cites this paper
• Two Target Regions of Allelic Loss on Chromosome 9 in Urinary‐bladder Cancer

  1999cites this paper
• Decreased DCC mRNA expression in human gastric cancers is clinicopathologically significant

  1998cites this paper
• Molecular Genetics in Carcinoma of the Bladder

  1998cites this paper
• Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancer.

  1998cites this paper
• Somatic alterations of the SMAD-2 gene in human colorectal cancers.

  1998cites this paper
• Molecular alterations in bladder cancer

  1998cites this paper
• Multiple truncated transcripts of TSG101 in gastrointestinal cancers

  1998cites this paper
• Genetic initiation, progression and prognostic markers in transitional cell carcinoma of the bladder: a summary of the structural and transcriptional changes, and the role of developmental genes.

  1998cites this paper
• PTCH gene mutations in invasive transitional cell carcinoma of the bladder

  1998cites this paper
• Genomic aberrations in renal cell carcinomas detected by restriction landmark genomic scanning.

  1998cites this paper
• Molecular genetics of bladder cancer: pathways of development and progression.

  1998cites this paper
• Molecular biological changes in bladder cancer.

  1998cites this paper
• Evidence that loss of chromosome 18q is associated with tumor progression.

  1997cites this paper
• Mutational state of tumor suppressor genes (DCC, DPC4) and alteration on chromosome 18q21 in human oral cancer.

  1997cites this paper
• The DCC protein -- neural development and the malignant process.

  1997cites this paper
• The TSG101 tumor susceptibility gene is located in chromosome 11 band p15 and is mutated in human breast cancer.

  1997cites this paper
• Frequent loss of heterozygosity on chromosome 10q in muscle-invasive transitional cell carcinomas of the bladder

  1997cites this paper
• Epidemiologie und Biologie des Harnblasenkarzinoms

  1997cites this paper
• Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma.

  1997cites this paper
• Cytogenetics of bladder cancer.

  1997cites this paper
• Genetics of bladder cancer

  1996cites this paper
• A molecular genetic model of human bladder cancer pathogenesis.

  1996cites this paper
• Transcriptional activation of H-ras, K-ras and N-ras proto-oncogenes in human bladder tumors.

  1996cites this paper
• Loss of 18q and homozygosity for the DCC locus: possible markers for clinically aggressive squamous cell carcinoma.

  1996cites this paper
• Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.

  1996cites this paper
• The DCC protein and prognosis in colorectal cancer.

  1996cites this paper
• Somatic alterations of the DPC4 gene in human colorectal cancers in vivo.

  1996cites this paper
• Somatic in vivo alterations of the JV18-1 gene at 18q21 in human lung cancers.

  1996cites this paper
• DCC: is there a connection between tumorigenesis and cell guidance molecules?

  1996cites this paper
• DPC4 gene in various tumor types.

  1996cites this paper
• Immunohistochemical analysis of nm23 protein in transitional cell carcinoma of the bladder.

  1996cites this paper
• Partial allelotype of carcinoma in situ of the human bladder.

  1995cites this paper
• Novel suppressor loci on chromosome 14q in primary bladder cancer.

  1995cites this paper
• DCC: linking tumour suppressor genes and altered cell surface interactions in cancer?

  1995cites this paper
• Allelotype of pancreatic adenocarcinoma using xenograft enrichment.

  1995cites this paper
• Molecular genetics of bladder cancer.

  1995cites this paper
• DCC: linking tumor suppressor genes and altered cell surface interactions in cancer?

  1995cites this paper